Authors: Proudfoot, JR Betageri, R Cardozo, M Gilmore, TA Glynn, S Hickey, ER Jakes, S Kabcenell, A Kirrane, TM Tibolla, AK Lukas, S Patel, UR Sharma, R Yazdanian, M Moss, N Beaulieu, PL Cameron, DR Ferland, JM Gauthier, J Gillard, J Gorys, V Poirier, M Rancourt, J Wernic, D Llinas-Brunet, M

Citation: Jr. Proudfoot et al., Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain, J MED CHEM, 44(15), 2001, pp. 2421-2431

Authors: Llinas-Brunet, M Bailey, M Fazal, G Ghiro, E Gorys, V Goulet, S Halmos, T Maurice, R Poirier, M Poupart, MA Rancourt, J Thibeault, D Wernic, D Lamarre, D

Citation: M. Llinas-brunet et al., Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: Towards smaller inhibitors, BIOORG MED, 10(20), 2000, pp. 2267-2270

Authors: Beaulieu, PL Anderson, PC Cameron, DR Croteau, G Gorys, V Grand-Maitre, C Lamarre, D Liard, F Paris, W Plamondon, L Soucy, F Thibeault, D Wernic, D Yoakim, C Pav, S Tong, L

Citation: Pl. Beaulieu et al., 2 ',6 '-dimethylphenoxyacetyl: A new achiral high affinity P-3-P-2 ligand for peptidomimetic-based HIV protease inhibitors, J MED CHEM, 43(6), 2000, pp. 1094-1108

Authors: Llinas-Brunet, M Beaulieu, PL Cameron, DR Ferland, JM Gauthier, J Ghiro, E Gillard, J Gorys, V Poirier, M Rancourt, J Wernic, D

Citation: M. Llinas-brunet et al., Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56(lck) SH2 domain, J MED CHEM, 42(4), 1999, pp. 722-729

Authors: Beaulieu, PL Cameron, DR Ferland, JM Gauthier, J Ghiro, E Gillard, J Gorys, V Poirier, M Rancourt, J Wernic, D Llinas-Brunet, M Betageri, R Cardozo, M Hickey, ER Ingraham, R Jakes, S Kabcenell, A Kirrane, T Lukas, S Patel, U Proudfoot, J Sharma, R Tong, L Moss, N

Citation: Pl. Beaulieu et al., Ligands for the tyrosine kinase p56(lck) SH2 domain: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements, J MED CHEM, 42(10), 1999, pp. 1757-1766